Aprea Therapeutics Inc (NAS:APRE)
$ 3.3 0.16 (5.1%) Market Cap: 17.07 Mil Enterprise Value: -11.72 Mil PE Ratio: 0 PB Ratio: 0.78 GF Score: 37/100

Aprea Therapeutics Inc to Host Key Opinion Leader (KOL) Event Transcript

Oct 31, 2023 / 03:00PM GMT
Release Date Price: $3.36 (-6.01%)
Operator

Good day, and welcome everyone to the Aprea Therapeutics KOL Event featuring presentations by esteemed key opinion leaders, Dr. Fiona Simpkins, professor in the division of gynecology oncology and department of OB-GYN at the University of Pennsylvania and Dr. Tim Yap, medical oncology physician-scientist and professor based at the University of Texas MD Anderson Cancer Center, who will speak today about key targets in oncology and tumor suppression, specifically synthetic lethality and DNA damage response pathways. We will also hear from Dr. Eric Brown, professor at the University of Pennsylvania and a member of the Abramson Family Cancer Research Institute; Dr. Nadeem Mirza, Senior Medical Advisor at Aprea; and Dr. Oren Gilad, President and Chief Executive Officer at Aprea; Dr. Gilad is a pioneer in the field of cancer research having authored several scientific publications during his 13-year academic career, including on the ATR pathway. All speakers will be available for a Q&A session following the formal presentations.

Let me remind everyone that during the event, speakers may make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot